JANX · Janux Therapeutics, Inc.

$16.26 +0.42 (+2.65%) At close · Jul 17

Market Cap

$991.61M

60,984,354

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Campbell	CEO	$680,000	—	—	$12,459,031	$367,200	—	$13,506,231
Byron Robinson	Chief Strategy Officer	$362,728	—	—	$4,306,826	—	$394,081	$5,063,635
Janeen Doyle	Chief Corporate and Business Development Officer	$309,963	$75,000	$995,280	$3,124,983	$114,066	$50,000	$4,669,292
Zachariah McIver	D.O., Ph.D. Former Chief Medical Officer	$475,000	—	—	$3,999,195	$165,300	—	$4,639,495
Thomas DiRaimondo	Chief Scientific Officer	$478,000	—	—	$3,691,565	$175,904	—	$4,345,469

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Campbell	CEO	$646,000	—	$4,981,500	$2,862,873	$484,500	—	$8,974,873
Tighe Reardon	CFO	—	—	—	$7,913,496	—	—	$7,913,496
Byron Robinson	Chief Strategy Officer	$485,000	—	$1,871,520	$1,216,621	$242,500	—	$3,815,641
Thomas DiRaimondo	Chief Scientific Officer	$420,000	—	$1,604,160	$1,180,484	$210,000	—	$3,414,644

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Campbell	CEO	$625,000	—	—	$3,155,769	$412,500	—	$4,193,269
Byron Robinson	Chief Strategy Officer	$450,000	$75,000	—	$1,017,990	$198,000	—	$1,740,990
Charles Winter	Chief Technical Officer	$410,000	—	—	$1,017,990	$180,400	—	$1,608,390

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Campbell	CEO	$550,000	—	—	$5,149,378	$302,500	—	$6,001,878
Byron Robinson	Chief Strategy Officer	$351,945	$100,000	—	$2,760,989	$154,856	—	$3,367,790
Wayne Godfrey	Chief Medical Officer	$435,000	—	—	$1,660,738	$191,400	—	$2,287,138
Charles Winter	Chief Technical Officer	$315,000	—	—	$1,133,808	$103,950	—	$1,552,758

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Campbell	CEO	$459,054	—	—	$7,721,848	$229,527	—	$8,410,429
Wayne Godfrey	Chief Medical Officer	$257,045	—	—	$3,918,086	$102,818	—	$4,277,949
Shahram Salek-Ardakani	Chief Scientific Officer	$189,394	$125,000	—	$3,638,223	$56,818	—	$4,009,435
Byron Robinson	Chief Strategy Officer	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Campbell	CEO	$405,117	$141,791	—	$225,868	—	$38,906	$811,682
Shahram Salek-Ardakani	Chief Scientific Officer	—	—	—	—	—	—	—
Wayne Godfrey	Chief Medical Officer	—	—	—	—	—	—	—

Key facts CIK 1817713 CUSIP 47103J105 13F (30d) 14 filings 13 filers Visit website Investor relations